readthroughSign in
CompanyAPVONasdaqSeattle, WA

Aptevo Therapeutics

Aptevo Therapeutics develops multispecific immunotherapies for cancer using its ADAPTIR and ADAPTIR-FLEX platform technologies.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 17Latest story